Correspondence (letter to the editor): Lucid scientific analysis.
Altwein
Jens E
JE
D000975:Antioxidants / Q000008:administration & dosage* / Q000009:adverse effects*; D019587:Dietary Supplements; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D011471:Prostatic Neoplasms / Q000139:chemically induced* / Q000473:pathology / Q000517:prevention & control; D017382:Reactive Oxygen Species; D012643:Selenium / Q000008:administration & dosage / Q000009:adverse effects; D014815:Vitamins / Q000008:administration & dosage* / Q000009:adverse effects*; D014920:Wine
D000975:Antioxidants; D017382:Reactive Oxygen Species; D014815:Vitamins; D012643:Selenium
Anticancer Res. 2004 Sep-Oct;24(5A):2783-840
15517885
J Natl Cancer Inst. 2007 May 16;99(10):754-64
17505071
JAMA. 2009 Jan 7;301(1):39-51
19066370
Dtsch Arztebl Int. 2009 Oct;106(42):677-84
19946436